Upcoming Deadlines

Mark your calendars:

BWF Spotlight

When Feroz Papa was an internal medicine resident at the University of California, San Francisco he treated many patients with diabetes, giving them insulin and other treatments designed to restore the body’s balance of glucose. But he always knew he wasn’t treating the root of the problem.

“There really weren’t any disease-modifying therapies aimed at the beta cell itself,” said Papa, who had always been interested in the molecular basis of diseases. “That sparked an interest to try to work in that arena,” he said.  [FULL STORY]